Research progress of oxaliplatin-based regimen for advanced hepatocellular carcinoma
10.3760/cma.j.issn.1673-422X.2016.07.017
- VernacularTitle:含奥沙利铂化疗方案治疗晚期原发性肝细胞癌的研究进展
- Author:
Didi SONG
;
Chuanyong LIU
- Publication Type:Journal Article
- Keywords:
Carcinoma,hepatocellular;
Drug therapy;
Oxaliplatin
- From:
Journal of International Oncology
2016;43(7):545-547
- CountryChina
- Language:Chinese
-
Abstract:
Sorafenib is currently the only systematic molecular targeted drug approved by many coun-tries for the treatment of advanced HCC.But sorafenib limites has survival improvement,patients appear inevi-table disease progression soon.In recent years,Oxaliplatin-based regimens showed promising anti-tumor activi-ty,safety and low toxicities,which provides a new way for treatment of advanced HCC.
